The Australian arthroplasty thromboprophylaxis survey
dc.contributor.author | Molnar, R. | |
dc.contributor.author | Jenkin, D. | |
dc.contributor.author | Millar, M. | |
dc.contributor.author | Campbell, D. | |
dc.contributor.author | Harris, I. | |
dc.date.issued | 2011 | |
dc.description.abstract | Previous surveys of orthopedic surgeons have shown considerable variation in thromboprophylaxis for venous thromboembolism after joint arthroplasty. This survey aimed to determine the current practice among Australian orthopedic surgeons. A questionnaire regarding the duration, reasons, and methods of chemical and mechanical prophylaxis for hip and knee arthroplasty patients was sent to the 1082 surgeons identified; 593 (55%) members completed the questionnaire. The survey revealed that 98% of surgeons used chemical thromboprophylaxis, mainly low-molecular-weight heparin (84% hip and 79% knee). Those who use low-molecular-weight heparin were more likely to prescribe anticoagulants in fear of litigation (19.2% vs 10.1%, P = .04) and more likely to rely on protocols or guidelines (32.2% vs 17.2%, P = .004) instead of basing their decision on their own reading (52.4% vs 71.3%, P = .001). Most orthopedic surgeons in our survey have indicated that they would welcome guidelines from their association or college regarding thromboprophylaxis in arthroplasty. | |
dc.description.statementofresponsibility | Robert B. Molnar, Deanne E. Jenkin, Michael J. Millar, David Campbell and Ian A. Harris | |
dc.identifier.citation | Journal of Arthroplasty, 2011; 27(2):173-179 | |
dc.identifier.doi | 10.1016/j.arth.2011.05.003 | |
dc.identifier.issn | 0883-5403 | |
dc.identifier.issn | 1532-8406 | |
dc.identifier.orcid | Campbell, D. [0000-0002-1572-9529] | |
dc.identifier.uri | http://hdl.handle.net/2440/71626 | |
dc.language.iso | en | |
dc.publisher | Churchill Livingstone Inc Medical Publishers | |
dc.rights | Copyright © 2012 Elsevier B.V. | |
dc.source.uri | https://doi.org/10.1016/j.arth.2011.05.003 | |
dc.subject | Humans | |
dc.subject | Aspirin | |
dc.subject | Warfarin | |
dc.subject | Heparin, Low-Molecular-Weight | |
dc.subject | Anticoagulants | |
dc.subject | Motion Therapy, Continuous Passive | |
dc.subject | Arthroplasty, Replacement, Hip | |
dc.subject | Arthroplasty, Replacement, Knee | |
dc.subject | Data Collection | |
dc.subject | Risk Factors | |
dc.subject | Attitude of Health Personnel | |
dc.subject | Australia | |
dc.subject | Practice Guidelines as Topic | |
dc.subject | Venous Thromboembolism | |
dc.subject | Surveys and Questionnaires | |
dc.subject | Practice Patterns, Physicians' | |
dc.title | The Australian arthroplasty thromboprophylaxis survey | |
dc.type | Journal article | |
pubs.publication-status | Published |